XOMA (XOMA) Stock Highlights

27.13 | +8.04%

2024-12-21 05:47:30

XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

Statistics

Range Today

24.54 27.49

Volume Today 132.2K

Range 1 Year

17.52 35

Volume 1 Year 5.8M

Range 3 Year

13.48 35

Volume 3 Year 22.67M

Range 10 Year

3.96 98.6

Volume 10 Year 195.89M

Highlights

Market Capitalization 362.49M (small)

Floating Shares 8.03M

Current Price 27.13

Price To Earnings -13.63

Price To Revenue 23.45

Price To Book 4.01

Earnings Per Share -2.25

Dividend Yield 6.69%

Dividend Per Share 2.16

Payout Ratio 0%

Performance

Latest +8.04%

1 Month -10.52%

3 Months -8.59%

6 Months +21.17%

1 Year +49.72%

3 Years +25.72%

5 Years +10.73%

10 Years -66.34%

Benchmarks

Market Capitalization

208 / 368

Gross Profits

107 / 278

Total Revenue

204 / 300

Total Rank

72 / 368

Free Cashflow

36 / 352

Performance 5 years

105 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.